AN2 Therapeutics, Inc. (ANTX) stock
ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.23−0.24 (-5.37%)
Close on Nov 17, 2026Market cap $159.62MP/E –Yield –
AN2 Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
AN2 Therapeutics's price to book ratio was 2.1× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.3× to 4.4×, with a median of 1.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.1× | +1.6 |
| 2025 | Dec 31, 2025 | 0.5× | +0.0 |
| 2024 | Dec 31, 2024 | 0.5× | −3.9 |
| 2023 | Dec 29, 2023 | 4.4× | +2.6 |
| 2022 | Dec 30, 2022 | 1.8× | – |
See a number that looks wrong?